Completed OBSERVATIONAL NCT00916786

Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder

Sponsor: National Science and Technology Council, Taiwan

Conditions Attention Deficit Hyperactivity Disorder

Updated 12 times since 2017 Last updated: Sep 1, 2021 Started: Aug 1, 2009 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Attention Deficit Hyperactivity Disorder, this trial is completed. The trial is conducted by National Science and Technology Council, Taiwan and has accumulated 12 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Jun 2025 — Present [monthly]

Completed
Sep 2024 — Jun 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Oct 2021 — Dec 2021 [monthly]

Completed

Status: Unknown Status → Completed

▶ Show 7 earlier versions

Jan 2021 — Oct 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status
Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Science and Technology Council, Taiwan
National Taiwan University Hospital

Data source: National Taiwan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan